腰大肌-L4椎体指数无法预测下肢血运重建术后无截肢生存
该回顾性队列研究纳入188例下肢血运重建患者,评估腰大肌-L4椎体指数(PLVI)对无截肢生存(AFS)的预测价值。结论认为PLVI不能预测外周动脉闭塞性疾病干预后的AFS。
要点
- PLVI不是下肢血运重建术后无截肢生存的独立预测因子。
- 年龄、充血性心力衰竭是AFS丧失的独立预测因素。
- 高PLVI与死亡率增加相关,但未预测截肢风险。
核心结论
- PLVI不能预测外周动脉闭塞性疾病干预后的无截肢生存。
- 该结果与PLVI能预测腹主动脉瘤修复及其他腹部大手术后生存的能力相反。
研究设计与样本
- 回顾性队列研究,纳入6年间有术前CT血管造影的下肢血运重建患者188例。
- 52%接受开放手术旁路,48%接受经皮腔内血管介入,中位随访12个月(IQR 3-24个月)。
- 使用CT软件测量L4水平双侧腰大肌和椎体横截面积计算PLVI。
- 采用单因素、多因素logistic回归和Cox比例风险分析评估主要结局AFS。
主要发现
- 中位双侧腰大肌横截面积为24.9 cm2(IQR 20.5-29.7 cm2),平均PLVI为1.74(IQR 1.39-2.05)。
- Kaplan-Meier分析显示最高和最低PLVI队列间生存无显著差异。
临床怎么用
- PLVI不宜用于下肢血运重建术后无截肢生存的风险分层。
- 评估下肢血运重建风险时应关注年龄、充血性心力衰竭、血脂异常等因素。
- 高PLVI患者死亡风险增加,但需进一步验证。
局限性
- 回顾性研究设计。
- 中位随访时间仅12个月,可能不足以观察长期结局。
- 样本量有限(188例),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate and convenient methods for assessing a patient's risk of postoperative morbidity and mortality comprise important tools in clinical decision-making. Whereas some aspects of the patient's fitness for surgery can be easily quantified, measurement of the patient's frailty is often difficult or time-consuming. Previous research in the context of multiple types of major surgical procedures has reported psoas-L4 vertebral index (PLVI) to be a useful predictor of postoperative morbidity and mortality. METHODS: This retrospective cohort study assessed the hypothesis that PLVI can predict amputation-free survival (AFS) in patients undergoing open or endovascular lower extremity revascularization. The records of all lower extremity revascularization patients with preoperative computed tomography arteriography before revascularization during a recent 6-year period were reviewed for demographic information and outcomes. With use of embedded computed tomography software, the cross-sectional area of the bilateral psoas muscles and vertebral body at the L4 level were measured and used to calculate the PLVI. Univariate, multivariate logistic regression, and Cox proportional hazards analyses were performed for the primary outcome of AFS. RESULTS: During a 6-year period, 188 patents had preoperative scanning, qualifying for inclusion in the study; 52% received open surgical bypass and 48% received a percutaneous endovascular procedure, with a median duration of follow-up of 12 months (interquartile range [IQR], 3-24 months). Median bilateral psoas cross-sectional area was 24.9 cm2 (IQR, 20.5-29.7 cm2), and mean PLVI was 1.74 (IQR, 1.39-2.05). Cox proportional hazards analysis identified age (hazard ratio [HR], 1.07; 95% confidence interval [CI], 1.01-1.14; P = .026), congestive heart failure (HR, 4.7; 95% CI, 1.29-16.9; P = .019), and dyslipidemia (HR, 0.34; 95% CI, 0.12-0.99; P = .049) as independent predictors of AFS loss, whereas PLVI was not (HR, 2.6; 95% CI, 0.83-8.39; P = .099). Kaplan-Meier life-table analysis demonstrated no significant differences in survival between the highest and lowest PLVI cohorts of patients. Hazard analysis showed concomitant congestive heart failure (HR, 15; 95% CI, 1.1-210; P = .042) and serum albumin concentration (HR, 0.16; 95% CI, 0.05-0.52; P = .0026) to be independent predictors of limb loss, whereas advanced age (HR, 1.20; 95% CI, 1.07-1.35; P = .0026), bypass procedure (HR, 4.6; 95% CI, 1.04-21; P = .045), non-African American race (HR, 9.09; 95% CI, 1.02-100; P = .048), and higher PLVI (HR, 10.9; 95% CI, 1.7-72; P = .013) predicted increased risk of mortality. CONCLUSIONS: PLVI did not predict AFS after intervention for peripheral arterial occlusive disease. This is contrary to the ability of PLVI to predict perioperative and midterm survival after abdominal aortic aneurysm repair and other major abdominal surgery.
引用
- Nyers ES, Brothers TE. Perioperative psoas to lumbar vertebral index does not successfully predict amputation-free survival after lower extremity revascularization. J Vasc Surg. 2017. PMID: 28847658. doi:10.1016/j.jvs.2017.06.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。